Home | Contact | Donate | Stay Connected

News

Our Dual Lens Approach

BVGH works to solve major global health problems by finding the common ground between the needs of patients in poor countries and the pragmatic needs of companies.

Intellectual Property Pool: Podcast with BVGH, Alnylam and GlaxoSmithKline

02/23/2010

BVGH CEO Melinda Moree discusses the Intellectual Property (IP) Pool to aid in the development of new treatments for neglected tropical diseases with Alnylam Pharmaceuticals CEO John Maraganore and Nick Cammack, Vice President and head of GlaxoSmithKline’s Tres Cantos Medicines Development Campus. BIO Ventures for Global Health was recently selected to administer the IP Pool. Listen to the podcast.

Home | Contact | Site Map

To help solve the global health crisis, biopharmaceutical innovation is needed. BIO Ventures for Global Health (BVGH) works to engage companies to drive partnerships and invest in global health initiatives that result in the new drugs, vaccines, and diagnostics that will save lives in poor countries.